Entera Bio
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Hadassah Bio Park Fl 5, Jerusalem, Jerus...Phone Number
+972 25327151Website
www.enterabio.comRevenue
-Stock Symbol
ENTXIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Entera Bio
Entera is a leader in the development of orally delivered macromolecules, including peptides and other therapeutic proteins. The Company focuses on significant unmet medical needs where a mini daily tablet form of a peptide treatment or replacement therapy holds the potential to transform the standard of care. The Company’s most advanced product candidates, EB613 for the treatment of high risk, post-menopausal osteoporosis and EB612 for the treatment of hypoparathyroidism, are in clinical development.Explore more
Entera Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Entera Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Entera Bio has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Entera Bio is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Entera Bio recently announced quarterly report
Product Launch: Get notified when Entera Bio launches new products
Congratulate Masked Content for being promoted to Masked Content at Entera Bio
Check if Entera Bio has recently received funding, and reach out quickly before it becomes old news!
Entera Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Entera Bio had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Entera Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Entera Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Entera Bio.
Entera Bio financials insights
Gather financial insights about Entera Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Debt
$7.5M
Entera Bio Tech Stack
A closer look at the technologies used by Entera Bio
Most Recent Scoops
Earnings
Earnings, Finance
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Entera Bio News & Media
Entera Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
TEL AVIV, July 31, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, Miranda Toledano, will be participating in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference, details as below.Greenberg Traurig Advises Entera Bio in Record $275M Israeli Biotech PIPE
MIAMI, July 29, 2026 /PRNewswire/ -- Global law firm Greenberg Traurig, P.A. advised Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides, in connection with its oversubscribed $275 million private placement financing. The financing is expected to extend Entera...Entera Bio raises $275m for Phase III osteoporosis drug trial - Globes English
The new funds from the private placement will finance the company until 2030.Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement
The offering is led by existing investor BVF Partners L.P.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Entera Bio
Sign Up For FreeTo access detailed company insights
Entera is a leader in the development of orally delivered macromolecules, including peptides and other therapeutic proteins. The Company focuses on significant unmet medical needs where a mini daily tablet form of a peptide treatment or replacement therapy holds the potential to transform the standard of care. The Company’s most advanced product ca... Read More
